SCOPUS 정보 검색 플랫폼

Current Opinion in Investigational Drugs

Volumn 3, Issue 1, 2002, Pages 89-95

Conivaptan: Yamanouchi

Author keywords

[No Author keywords available]

Indexed keywords

ARGIPRESSIN; BENZAZEPINE DERIVATIVE; CONIVAPTAN; FUROSEMIDE; POTASSIUM; SODIUM; VASOPRESSIN RECEPTOR ANTAGONIST; VASOPRESSIN V1 RECEPTOR; VASOPRESSIN V2 RECEPTOR; YM 35087;

CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONSTIPATION; DIURETIC ACTIVITY; DOSE RESPONSE; DRUG ACTIVITY; DRUG BIOAVAILABILITY; DRUG COST; DRUG EFFICACY; DRUG HALF LIFE; DRUG MARKETING; DRUG MEGADOSE; DRUG METABOLISM; DRUG RECEPTOR BINDING; DRUG SAFETY; DRUG STRUCTURE; DRUG SYNTHESIS; EDEMA; HEART FAILURE; HUMAN; HYPONATREMIA; HYPOTENSION; IN VITRO STUDY; NONHUMAN; POTASSIUM EXCRETION; PRESSOR RESPONSE; REVIEW; SODIUM EXCRETION; STRUCTURE ACTIVITY RELATION; URINE FLOW RATE; URINE OSMOLALITY; VERTIGO; ANIMAL; CHEMISTRY; METHODOLOGY; PHARMACEUTICS; STATISTICS;

ANIMAL; BENZAZEPINES; CLINICAL TRIALS; EDEMA; HEART FAILURE, CONGESTIVE; HUMAN; HYPONATREMIA; TECHNOLOGY, PHARMACEUTICAL; ANIMALS; HUMANS;

EID: 0035985614 PISSN: 14724472 EISSN: None Source Type: Journal
DOI: None Document Type: Review

Times cited : (16)

References (40)

1
- 0004218947
- Annual Report 1997 - Yamanouchi Pharmaceutical Co
- 270568
- Yamanouchi Pharmaceutical Co Ltd Annual Report 1997 March 31

2
- 0031039813
- 2 receptor antagonist, in dogs
- 281808; note
- (1997) Eur J Pharmacol , vol.321 , Issue.2 , pp. 225
- Yatsu, T.¹ Tomura, Y.² Tahara, A.³ Wada, K.⁴ Tsukade, J.⁵ Uchida, W.⁶ Tanaka, A.⁷ Takenaka, T.⁸

3
- 0005107527
- American Chemical Society 216th National Meeting (Part VIII), Boston, MA, USA
- 297320
- IDDB Meeting Report 1998 August 23-27

4
- 0030583716
- 8-oxytocin (antocin) in human kidney and liver homogenates
- 303354; note
- (1996) Regul Pept , vol.67 , Issue.1 , pp. 27-32
- Fjellestad Paulsen, A.¹ Lundin, S.²

5
- 0030730133
- 2 receptor antagonists
- 306667; note
- (1997) Curr Pharm Design , vol.3 , Issue.6 , pp. 615-632
- Albright, J.D.¹ Chan, P.S.²

6
- 0032967275
- Nonpeptide vasopressin antagonists: A new group of hormone blockers entering the scene
- 329378; note
- (1999) J Exp Clin Endocrinology Diabetes , vol.107 , Issue.3 , pp. 157-165
- Mayinger, B.¹ Hensen, J.²

7
- 7844251895
- Pharmacological characterization of the human vasopressin receptor subtypes stably expressed in Chinese hamster ovary cells
- 332591; note
- (1998) Br J Pharmacol , vol.125 , Issue.7 , pp. 1463-1470
- Tahara, A.¹ Saito, M.² Sugimoto, T.³ Tomura, Y.⁴ Wada, K.⁵ Kusayama, T.⁶ Tsukada, J.⁷ Ishii, N.⁸ Yatsu, T.⁹ Uchida, W.¹⁰ Tanaka, A.¹¹

8
- 0032051870
- Effect of YM087, a potent nonpeptide vasopressin antagonist, on vasopressin-induced protein synthesis in neonatal rat cardiomyocyte
- 332626; note
- (1998) Cardiovasc Res , vol.38 , Issue.1 , pp. 198-205
- Tahara, A.¹ Tomura, Y.² Wada, K.³ Kusayama, T.⁴ Tsukada, J.⁵ Ishii, N.⁶ Yatsu, T.⁷ Uchida, W.⁸ Tanaka, A.⁹

9
- 0004346572
- Neurohypophysial Hormones - 1999 World Congress, Edinburgh, UK
- 339031
- IDDB Meeting Report 1999 August 28 - September 2
- Leng, G.¹

10
- 0006081701
- Japan Combinatorial Chemistry Focus Group - Ninth Biannual Meeting, Kawasaki, Japan
- 348119
- IDDB Meeting Report 1999 November 10-11

11
- 0006135317
- 2 Vasopressin antagonist YM087
- 348480; Abs 1562; note
- (1999) Am Heart Assoc , vol.72
- Abraham, W.T.¹ Suresh, D.P.² Wagoner, L.E.³ Haas, G.J.⁴ McCord, J.⁵ Rydzinski, S.⁶ Nelson, C.B.⁷ Bakker Arkema, R.G.⁸

12
- 0032988191
- 2 receptor antagonist, in dogs with pacing-induced congestive heart failure
- 349112; note
- (1999) Eur J Pharmacol , vol.376 , Issue.3 , pp. 239-246
- Yatsu, T.¹ Tomura, Y.² Tahara, A.³ Wada, K.⁴ Kusayama, T.⁵ Tsukada, J.⁶ Tokioka, T.⁷ Uchida, W.⁸ Inagaki, O.⁹ Iizumi, Y.¹⁰ Tanaka, A.¹¹ Honda, K.¹²

13
- 0033014807
- Vasopressin increases vascular endothelial growth factor secretion from human vascular smooth muscle cells
- 353233; note
- (1999) Eur J Pharmacol , vol.368 , Issue.1 , pp. 89-94
- Tahara, A.¹ Saito, M.² Tsukada, J.³ Ishii, N.⁴ Tomura, Y.⁵ Wada, K.⁶ Kusayama, T.⁷ Yatsu, T.⁸ Uchida, W.⁹ Tanaka, A.¹⁰

14
- 0034054389
- Editorial overview: Arrhythmia and heart failure
- 355468
- (2000) Curr Opin Cardiovasc Pulm Renal Invest Drugs , vol.2 , Issue.1 , pp. 7-8
- Knight, D.R.¹ Colatsky, T.J.²

15
- 0032981773
- Pharmacological profile of orally administered YM087, a vasopressin antagonist, in conscious rats
- 360045
- (1999) Clin Exp Pharmacol Physiol , vol.26 , pp. 399-403
- Tomura, Y.¹ Tahara, A.² Tsukada, J.³ Yatsu, T.⁴ Uchida, W.⁵ Iizumi, Y.⁶ Honda, K.⁷

16
- 0006045516
- Yamanouchi to start independent marketing in the US in 2002
- 362201
- (2000) Pharma Jpn , vol.1690 , pp. 1-2

17
- 15844366517
- Yamanouchi's new drugs R&D pipeline
- 377561
- (2000) Pharma Jpn , vol.1707 , pp. 8

18
- 0000942345
- 2A receptor antagonist, in patients with NYHA class III/IV heart failure
- 389545
- (2000) Circulation , vol.102 , Issue.18 , pp. 2603
- Painchaud, C.A.¹ Ghazzi, M.M.² Selaru, P.³ Richet, D.G.⁴ Chartier, K.K.⁵ Udelson, J.E.⁶

19
- 0004337082
- American Heart Association 73rd Scientific Sessions - Overnight Report (Part II), New Orleans, LA, USA
- 389663
- IDDB Meeting Report 2000 November 12-15
- Ahmed, T.¹

20
- 0000942343
- 2 receptor antagonist in patients with advanced heart failure
- 391515; Abs 2875
- (2000) Circulation , vol.102 , Issue.18
- Udelson, J.E.¹ Smith, W.B.² Hendrix, G.H.Q.³ Painchaud, C.A.⁴ Ghazzi, M.M.⁵ Ghali, J.K.⁶ Selaru, P.⁷ Pressler, M.L.⁸ Konstam, M.A.⁹ Thomas, I.¹⁰

21
- 0003308316
- 2 vasopressin antagonist YM087
- 392225; Prog Abs Issue 1119A; note
- (1999) J Am Soc Nephrol , vol.9
- Bichet, D.G.¹ Madore, F.² Cusson, J.³ Arthus, M.F.⁴ Lonergan, M.⁵ Nelson, C.B.⁶ Bakker Arkema, R.G.⁷

22
- 0005506351
- Global Healthcare Bulletin
- 397901; November 17
- (2000) Merrill Lynch Capital Markets

23
- 0006080460
- Yamanouchi Pharmaceutical licenses vasopressin receptor antagonist now under development to US-based Warner-Lambert Company
- 399433; May 07
- (1998) Yamanouchi Pharmaceutical Co Ltd Press Release

24
- 0034517098
- Conivaptan hydrochloride
- 400524
- (2000) Drugs Future , vol.25 , Issue.11 , pp. 1121-1130
- Norman, P.¹ Leeson, P.A.² Rabasseda, X.³ Castaner, J.⁴ Castaner, R.M.⁵

25
- 0034069082
- Vasopressin receptor antagonism - A therapeutic option in heart failure and hypertension
- 406415; note
- (2000) Exp Physiol , vol.85 S , Issue.SPEC. ISSUE
- Burrell, L.M.¹ Risvanis, J.² Johnston, C.I.³ Naitoh, M.⁴ Balding, L.C.⁵

26
- 0033429839
- Current status of acute intravenous therapy for chronic heart failure exacerbations
- 406420; note
- (1999) Prevention Management Congestive Heart Failure , vol.5 , Issue.5
- Taneja, T.¹ Johnson, M.R.² Gheorghiade, M.³

27
- 0032755258
- 2 receptor antagonist
- 406425; note
- (1999) Folia Pharmacol Jpn , vol.114
- Yatsu, T.¹ Tomura, Y.² Tahara, A.³ Wada, K.⁴ Kusayama, T.⁵ Tsukada, J.⁶ Tanaka, A.⁷ Iizumi, Y.⁸ Honda, K.⁹

28
- 0032879771
- 2 receptor antagonist (YM087) in the rat
- 406427; note
- (1999) Eur J Pharmacol , vol.381 , Issue.1 , pp. 23-30
- Risvanis, J.¹ Naitoh, M.² Johnston, C.I.³ Burrell, L.M.⁴

29
- 0031922116
- Development and therapeutic indications of orally-active non-peptide vasopressin receptor antagonists
- 406432; note
- (1998) Expert Opin Investig Drugs , vol.7 , Issue.5 , pp. 729-740
- Thibonnier, M.¹

30
- 0032051654
- Binding characteristics of YM087, an AVP receptor antagonist, in rhesus monkey liver and kidney membranes
- 406435; note
- (1998) Peptides , vol.19 , Issue.4 , pp. 691-696
- Tahara, A.¹ Tomura, Y.² Wada, K.³ Kusayama, T.⁴ Tsukada, J.⁵ Ishii, N.⁶ Yatsu, T.⁷ Uchida, W.⁸ Tanaka, A.⁹

31
- 15444339098
- 2 receptor antagonist
- 406443; note
- (1998) Naunyn Schmiedebergs Arch Pharmacol , vol.357 , Issue.1 , pp. 63-69
- Tahara, A.¹ Saito, M.² Sugimoto, T.³ Tomura, Y.⁴ Wada, K.⁵ Kusayama, T.⁶ Tsukada, J.⁷ Ishii, N.⁸ Yatsu, T.⁹ Uchida, W.¹⁰ Tanaka, A.¹¹

32
- 0031405967
- Effect of YM087, a potent nonpeptide vasopressin antagonist, on vasopressin-induced hyperplasia and hypertrophy of cultured vascular smooth-muscle cells
- 406447; note
- (1997) J Cardiovasc Pharmacol , vol.30 , Issue.6 , pp. 759-766
- Tahara, A.¹ Tomura, Y.² Wada, K.³ Kusayama, T.⁴ Tsukada, J.⁵ Ishii, N.⁶ Yatsu, T.⁷ Uchida, W.⁸ Tanaka, A.⁹

33
- 0030770540
- 2 receptor antagonist, in vitro and in vivo
- 406452; note
- (1997) J Pharmacol Exp Ther , vol.282 , Issue.1 , pp. 301-308
- Tahara, A.¹ Tomura, Y.² Wada, K.I.³ Kusayama, T.⁴ Tsukada, J.⁵ Takanashi, M.⁶ Yatsu, T.⁷ Uchida, W.⁸ Tanaka, A.⁹

34
- 0003310764
- 1 receptors in humans by conivaptan (YM087): Dose-dependent inhibition of vasopressin-induced platelet aggregation after single oral dose
- 406460; note
- (2000) Eur Heart J , vol.21 , Issue.ABS SUPPL. 594
- Strasser, R.¹ Van Den Hoyen, W.E.² Harmsen, A.R.³ Verschoor, H.S.⁴ Terpstra, I.J.⁵

35
- 0001012522
- 2 receptor antagonist, conivaptan (YM087) administered orally
- 406463; note
- (2000) Eur Heart J , vol.21 , Issue.ABS. SUPPL. 345
- Abraham, W.¹ Suresh, D.P.² Wagoner, L.E.³ Haas, G.J.⁴ Nelson, C.⁵ Bakker Arkema, R.G.⁶

36
- 0001012523
- 2 receptor antagonist
- 406466; note
- (2000) Eur Heart J , vol.21 , Issue.ABS. SUPPL. 345
- Abraham, W.¹ Koren, M.² Bichet, D.G.³ Verbalis, J.G.⁴ Klapholz, M.⁵ Selaru, P.⁶ Bakker Arkema, R.G.⁷ Rummel, S.A.⁸

37
- 84923920517
- Research and development pipeline
- 411763; 2001 June 06

38
- 0003293550
- Industry - Healthcare (pharmaceuticals): Wait-&-See Stance Retained; Valuations more attractive
- 422782; September 11
- (2001) Morgan Stanley Dean Witter
- Mita, M.¹

39
- 0003235749
- US Major Pharmaceuticals - Third quarter 2001 data book
- 423954; September 20
- (2001) Credit Suisse First Boston
- Kulju, K.¹ Beall, M.A.² Whysall, C.³

40
- 0035348291
- Long-term treatment of patients with innapropriate secretion of antidiuretic hormone by the vasopressin receptor conivaptan, urea or furosemide
- 429523
- (2001) Am J Med , vol.110 , Issue.7 , pp. 582-584
- Decaux, G.¹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.